Lung cancer is the #1 cancer killer of both women and men in the U.S., and every five minutes a woman in this country learns she has lung cancer. LUNG FORCE, led by the American Lung Association, unites women and their loved ones across the country to stand together against lung cancer. Join us to increase lung cancer awareness, promote research to beat this terrible disease, advocate for critical funding and fight for the lives of those affected by lung cancer. Your voice and support can help us make a difference.
Augtyro ‘Fills a Gap’ in the Treatment of ROS1-Positive NSCLC
December 4th 2023The recent FDA approval of the next-generation tyrosine kinase inhibitor Augtyro provides patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer another treatment option when the disease becomes resistant to other therapies.
Read More
Cancer Survivor Meets Neighbor With Same Diagnosis: ‘That Changed My World’
November 11th 2021On this episode of the “Cancer Horizons” podcast, a young mother living with lung cancer shares the story of her cancer diagnosis and describes the once-in-a-lifetime coincidence of learning her neighbor has the same cancer type and mutation.
Listen
Behind America’s Number One Cancer Killer: Most People Lack Awareness of Lung Cancer and Screenings
November 8th 2021The majority of Americans lack understanding of lung cancer’s deadly threat and how it can be screened for, according to new survey data from the American Lung Association. One survivor and one patient stress the importance of learning more about the deadliness of the disease.
Read More
Exkivity FDA Approval a ‘Compelling’ Solution as First Oral Therapy for Lung Cancer Subset
September 28th 2021Here’s what patients should know about the recent FDA approval of Exkivity, the first oral therapy for patients with non-small cell lung cancer who have EFGR exon 20 insertion mutations.
Read More